Scynexis to recall antifungal from market, pause studies

Scynexis

25/09/2023 13:45

Sept 25 (Reuters) - Drugmaker Scynexis  SCYX.O  said on
Monday it would voluntarily recall its antifungal drug
Brexafemme from the market and put a temporary hold on studies
of the therapy due to the potential risk of cross contamination
with another compound. 
    Scynexis said it became aware that substances used to make
beta-lactam, which can cause allergic reactions, are
manufactured using equipment common to the manufacturing process
for Brexafemme.
    

 (Reporting by Manas Mishra in Bengaluru; Editing by Krishna
Chandra Eluri)
 ((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manaswrites15;))